Infectious Disease Drug Development

Global Solutions for Infectious Disease Testing and Drug Development

Q2 Solutions offers testing capabilities for bacterial pathogens and viral infectious agents. We also have the scientific and technical expertise available to work on study specific methodologies and assay developments with our Bioanalytical and Genomics laboratories.

Q2 Solutions has two Infectious Disease and Vaccine centers of excellence: San Juan Capistrano, California, USA and Pretoria, South Africa. In many instances, these centers of excellence work collaboratively on trials depending on the trial location. Our customers have access to a multi-faceted global vaccine network, where we provide insight into regulations, customs and sample requirements for global, local or regional studies.

View our extensive test menu of standard and custom efficacy and immunogenicity assays for infectious disease testing. Learn more about our Infectious Disease testing capabilities by viewing our assets below.
Vaccine and Infectious Disease Testing Capabilities

End-to-end Laboratory Testing for Infectious Diseases and Vaccine Development

Tuberculosis (TB) Testing Capabilities

State-of-the-art technologies, quality management systems, and high-quality infrastructure to address the full spectrum of your TB testing needs

New Approaches for Malaria Vaccine Development

How advances in genetic engineering have brought new hope to conquering malaria

Q2 Solutions Anti-infective and Vaccine Development Services

Harnessing innovative technologies for clinical trials involving emerging and re-emerging infectious diseases

Tools for better management of infectious disease clinical trials

Read More